TITLE

STRESSGEN/ROCHE TO DEVELOP/MARKET HPV VACCINE

PUB. DATE
August 2002
SOURCE
Worldwide Biotech;Aug2002, Vol. 14 Issue 8, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the formation of a partnership between Stressgen Biotechnologies Corp. and Roche in 2002, for the marketing and development of a therapeutic vaccine for human papillomavirus.
ACCESSION #
7095468

 

Related Articles

  • SNDA FILED FOR XENICAL AS TYPE 2 DIABETES TREATMENT OPTION.  // Worldwide Biotech;May2001, Vol. 13 Issue 5, p3 

    Reports that Roche has announced that a supplemental New Drug Application has been submitted to the United States Food and Drug Administration for Xenical.

  • Roche moves OTC work in central Europe to Saatchi.  // Advertising Age's Euromarketing;8/6/96, Vol. 9 Issue 47, p1 

    Reports that Roche Consumer Health of eastern Europe has awarded Saatchi & Saatchi the advertising accounts for its Supradyn, Rennie, Aspro and Bepanthene brands. Value of the account.

  • Roche invests in proteomics programme.  // Life Science Today;Dec2000, Vol. 1 Issue 6, p7 

    Focuses on the total amount of money allotted by Roche to link proteomics research in the pharmaceuticals and diagnostics division of the company in Switzerland. Description of proteomics; Accounts on the gene function in the post-genomic era; Identification of the protein used as potential...

  • Roche. Valdmanis, Thor // Financial World;5/20/96, Vol. 165 Issue 8, p24 

    Features Swiss drugmaker Roche. Merger of Roche's rivals Sandoz and Ciba-Geigy; Displacement of Roche as a Switzerland's top pharmaceutical concern; Growing trend towards large pharmaceutical companies worldwide.

  • No sale.  // WWD: Women's Wear Daily;2/7/1997, Vol. 173 Issue 26, p10 

    Reports on the impact of Roche Holdings Ltd.'s announcement to acquire a United States-based flavors business on speculations about the sale of Givaudan-Roure, its fragrance flavors division.

  • Roche rush.  // njbiz;7/2/2012, Vol. 25 Issue 27, p11 

    The article contends that to say that the decision of pharmaceutical company Roche to close its Nutley, New Jersey, operation came as a shock would be an understatement.

  • Lean growth. Gopal, Kevin // Pharmaceutical Executive;Dec97, Vol. 17 Issue 12, p34 

    Reports on the plan of Roche to streamline the number of its employees following the integration of Boehringer Mannheim and DePuy units. Plans to minimize compulsory redundancies and implement reductions in socially responsible manner; Offering of positions at other sites to staff.

  • Roche's Oseltamivir: Scrutiny, Bird Flu, and New Drug Applications.  // Internal Medicine Alert;4/15/2007, Vol. 29 Issue 7, p2 

    The article reports that the drug oseltamivir (Tamiflu) from Roche was scrutinized in Japan after two students who took the drug died.

  • India Revokes Roche Patent in New Blow for Big Pharma. KULKARNI, KAUSTUBH; HIRSCHLER, BEN // News India Times;11/ 9/2012, Vol. 43 Issue 45, p21 

    The article presents information on a revoking of a patent granted to the company Roche in India.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics